middle.news
How Immutep’s Efti Combo Is Changing the Soft Tissue Sarcoma Landscape
1:47am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
How Immutep’s Efti Combo Is Changing the Soft Tissue Sarcoma Landscape
1:47am on Monday 2nd of June, 2025 AEST
Key Points
Efti with radiotherapy and KEYTRUDA® exceeded primary endpoint of tumor hyalinization/fibrosis
Median tumor hyalinization/fibrosis reached 50%, surpassing historical radiotherapy data
Trial enrolled 40 patients with resectable soft tissue sarcoma in Poland
Results support efti’s role in activating immune response against sarcoma tumors
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IMM
OPEN ARTICLE